# CIRculating Cell-free nUcLeic Acids in Cancer Therapy Monitoring -01

> **NCT05871593** · NA · NOT_YET_RECRUITING · sponsor: **University Hospital Tuebingen** · enrollment: 200 (estimated)

## Conditions studied

- Next-Generation-Sequencing

## Interventions

- **GENETIC:** Molecular genetic diagnostic

## Key facts

- **NCT ID:** NCT05871593
- **Lead sponsor:** University Hospital Tuebingen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2023-10
- **Primary completion:** 2025-10
- **Final completion:** 2026-10
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2023-05-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05871593

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05871593, "CIRculating Cell-free nUcLeic Acids in Cancer Therapy Monitoring -01". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05871593. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*